AlloVir Stock (NASDAQ: ALVR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 388.44K |
Day Range | - - - |
52 Wk Range | 0.58 - 3.75 |
Market Cap | $91.00M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 9.77% |
Days to Cover | 6.47 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AlloVir (NASDAQ:ALVR) through any online brokerage.
Other companies in AlloVir’s space includes: Serina Therapeutics (AMEX:SER), Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO) and Sangamo Therapeutics (NASDAQ:SGMO).
There is no analysis for AlloVir.
AlloVir has a consensus price target of $39.19.
The stock price for AlloVir (NASDAQ: ALVR) is $0.7913 last updated July 23, 2024 at 5:14 PM EDT.
There are no upcoming dividends for AlloVir.
AlloVir’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for AlloVir.
AlloVir is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.